1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. FULCRUM THERAPEUTICS INC
Fulcrum Therapeutics Inc XNAS: FULC

Fulcrum Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...

Read More
6.90 -0.69 (-9.09%)
31.89% Fall from 52W High
1.8M
XNAS Volume
High vol. this week

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The board meeting for Fulcrum Therapeutics Inc is scheduled for today, for the purpose of Fulcrum Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
19.3 / 100
Momentum Score
Technically Moderately Bullish
66.6 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
11
1Yr Price target upside is 60%
7 analysts

13

S

8

W

1

O

2

T

SWOT Analysis

Fulcrum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..